Revised SPC: Imfinzi (durvalumab) 50 mg/mL concentrate for solution for infusion
SPC updated with addition of alternative dosing regimen of 1500 mg every 4 weeks locally advanced NSCLC.
Source:
electronic Medicines compendium
SPC updated with addition of alternative dosing regimen of 1500 mg every 4 weeks locally advanced NSCLC.
electronic Medicines compendium